Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederroche.com
Get the latest updates from Investor Update directly as they happen.
Follow now 319 followers
Last updated 5 days ago
5 days ago
Roche will publish its Sales for the 3rd Quarter of 2024 prior...
7 days ago
Positive data confirm Evrysdi efficacy and safety in children first treated pre-symptomatically...
10 days ago
Basel, 11 October 2024 - Roche announced today its submission of greenhouse...
10 days ago
Approval is based on Phase III INAVO120 results, showing the Itovebi™ (inavolisib)-based...
13 days ago
We are pleased to invite investors and analysts to participate in our...
25 days ago
Positive phase III results for Roche’s Gazyva/Gazyvaro show superiority to standard therapy...
27 days ago
New TAGS (Temperature-Activated Generation of Signal) technology enables up to 15 targets...
28 days ago
Roche will publish its Sales for the 3rd Quarter of 2024 prior...
about 1 month ago
The Roche Investor Relations team would like to invite you to the...
about 1 month ago
Data from the CENTERSTONE study shows single-dose Xofluza reduces transmission of influenza...
about 1 month ago
OCREVUS ZUNOVO™ has the potential to expand treatment options to centres without...
about 1 month ago
Tecentriq Hybreza provides patients and physicians with greater flexibility of treatment options...